Do quality management systems influence clinical safety culture and leadership? A study in 32 Australian hospitals [PDF]
Robyn Clay‐Williams +5 more
openalex +1 more source
[Benefits and approaches of a quality management system in biomedical research laboratories]. [PDF]
Brünschwitz S, Kleymann-Hilmes J.
europepmc +1 more source
Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock +4 more
wiley +1 more source
Quality Management System in Pharmaceuticals: Principles, Practice, and Modernization
Deepjyoti Das
openalex +1 more source
Strengthening the clinical laboratory workforce in Cambodia: a case study of a mixed-method in-service training program to improve laboratory quality management system oversight. [PDF]
Ong SK +7 more
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Air quality impact of intelligent transportation system actions used in a decision support system for adaptive traffic management [PDF]
Beckx, C +11 more
core +1 more source
Quality Management System: Analisis Raport Mutu Usaha Kesehatan Sekolah (UKS)
Sapto Irawan, Danu Prasetyo
openalex +2 more sources
Do they really coexist? An empirical analysis of a conjoint implementation of Quality Management System and High Performance Work System on organizational effectiveness. [PDF]
Rehmani K, Ahmad Y, Naseem A, Syed TH.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source

